First Foundation Advisors Becton Dickinson & CO Transaction History

First Foundation Advisors

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	SELL	$233.45 - $247.73 $14,707 - $15,606	-63 Reduced 9.45%	604 $149,000
Q4 2023 Feb 14, 2024	SELL	$232.24 - $267.23 $167,909 - $193,207	-723 Reduced 52.01%	667 $162,000
Q3 2023 Nov 15, 2023	BUY	$254.9 - $283.59 $35,431 - $39,419	139 Added 11.11%	1,390 $359,000
Q2 2023 Aug 14, 2023	BUY	$238.39 - $265.32 $71,040 - $79,065	298 Added 31.27%	1,251 $330,000
Q1 2023 May 12, 2023	BUY	$229.71 - $259.35 $4,823 - $5,446	21 Added 2.25%	953 $235,000
Q4 2022 Feb 14, 2023	BUY	$218.29 - $256.91 $203,446 - $239,440	932 New	932 $237,000

1,737

250M

690K

787K

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $63.9B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

Get notified when there are updates to the investment portfolio of First Foundation Advisors, based on Form 13F filings with the SEC.

Stay updated on First Foundation Advisors with notifications on news.